Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $698M | $695.4M | +0.37% |
Cost of Revenue | $466.1M | $465.2M | +0.19% |
Gross Profit | $231.9M | $230.2M | +0.74% |
Operating Income | $107M | $122.8M | -12.87% |
Net Income | $89.8M | $115.3M | -22.12% |
EPS (Basic) | $1.24 | $1.57 | -21.02% |
EPS (Diluted) | $1.23 | $1.55 | -20.65% |
R&D Expense | $16.3M | $17.6M | -7.39% |
SG&A Expense | $88M | $86.7M | +1.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.62B | $3.6B | +0.44% |
Current Assets | $1.46B | $1.69B | -13.91% |
Total Liabilities | $935.1M | $921.7M | +1.45% |
Current Liabilities | $526.7M | $648.4M | -18.77% |
Stockholders' Equity | $2.68B | $2.68B | +0.09% |
Cash & Equivalents | $404.2M | $601.8M | -32.83% |
Long-Term Debt | $202.6M | $206.2M | -1.75% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $129.4M | $118.2M | +9.48% |
Investing Cash Flow | $-71.3M | $-90.6M | +21.30% |
Financing Cash Flow | $-147M | $-271M | +45.76% |
Share Buybacks | $133.5M | $267M | -50.00% |
D&A | $40M | $35.6M | +12.36% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 33.2% | 33.1% | +0.12% |
Operating Margin | 15.3% | 17.7% | -2.33% |
Net Margin | 12.9% | — | — |
ROE | 3.3% | — | — |
ROA | 2.5% | — | — |
Current Ratio | $2.767 | — | — |
Debt to Equity | $0.349 | — | — |
Other companies in Life Sciences Tools & Services